COL12A1 (Figure 7A), PLEC (Figure 7C), and SLC4A1 (Figure 7E) expression levels were significantly increased in serous ovarian tumors (grade 3) that did not respond to platinum and taxane chemotherapy compared to responders after 6 months of treatment. Here, SLC4A1 is linked to ovarian serous tumor.